AFP - FRANKFURT, Germany (AFP) - The German pharmaceutical group Fresenius announced on Monday the purchase of U.S. company PDB, which specialises in generic drugs by intravenous, by 3,700 million dollars.
In depth - most viewed: Phoenix Ancient Art
